WallStreetZenWallStreetZen

NYSEMKT: AZTR
Azitra Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their AZTR stock forecasts and price targets.

Forecast return on equity

Is AZTR forecast to generate an efficient return?

Company
N/A
Industry
349.4%
Market
203.54%

Forecast return on assets

Is AZTR forecast to generate an efficient return on assets?

Company
N/A
Industry
120.28%

AZTR earnings per share forecast

What is AZTR's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.14
Avg 2 year Forecast
-$2.89

AZTR revenue forecast

What is AZTR's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$20.7M

AZTR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AZTR$0.28N/AN/A
CANF$4.47$3.25-27.29%Strong Buy
ENSC$0.85N/AN/A
INM$1.07N/AN/A
XRTX$0.54N/AN/A
View Top Biotech Stocks

Azitra Stock Forecast FAQ

What is AZTR's earnings growth forecast for 2026-2027?

(NYSEMKT: AZTR) Azitra's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 68.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.67%.

Azitra's earnings in 2026 is -$11,114,999.On average, 4 Wall Street analysts forecast AZTR's earnings for 2026 to be -$11,606,076, with the lowest AZTR earnings forecast at -$13,501,133, and the highest AZTR earnings forecast at -$9,429,363.

In 2027, AZTR is forecast to generate -$29,521,865 in earnings, with the lowest earnings forecast at -$42,628,067 and the highest earnings forecast at -$15,108,411.

If you're new to stock investing, here's how to buy Azitra stock.

What is AZTR's revenue growth forecast for 2026-2028?

(NYSEMKT: AZTR) Azitra's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.58%.

Azitra's revenue in 2026 is $0.On average, 4 Wall Street analysts forecast AZTR's revenue for 2026 to be $0, with the lowest AZTR revenue forecast at $0, and the highest AZTR revenue forecast at $0. On average, 4 Wall Street analysts forecast AZTR's revenue for 2027 to be $0, with the lowest AZTR revenue forecast at $0, and the highest AZTR revenue forecast at $0.

In 2028, AZTR is forecast to generate $210,997,298 in revenue, with the lowest revenue forecast at $202,731,298 and the highest revenue forecast at $217,212,105.

What is AZTR's forecast return on assets (ROA) for 2026-2029?

(NYSEMKT: AZTR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 120.28%.

What is AZTR's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSEMKT: AZTR) Azitra's current Earnings Per Share (EPS) is -$1.60. On average, analysts forecast that AZTR's EPS will be -$1.14 for 2026, with the lowest EPS forecast at -$1.32, and the highest EPS forecast at -$0.92. In 2027, AZTR's EPS is forecast to hit -$2.89 (min: -$4.18, max: -$1.48).

What is AZTR's forecast return on equity (ROE) for 2026-2029?

(NYSEMKT: AZTR) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.